The activation of M <sub>3</sub> muscarinic receptor reverses liver injuryvia the Sp1/lncRNA Gm2199/miR-212 axis
2022
Zhang Haiying | Gao Yanan | Liu Bin | Jin Haobin | Fan Li | Yang Xirui | Gao Qiang | Yu Yi | Guo Yueping | Liu Yan
Muscarinic acetylcholine receptors (MRs) play important roles in the regulation of hepatic fibrosis and the receptor agonists and antagonists can affect hepatocyte proliferation. However, little is known about the impact of M <sub>3</sub>R subtypes and associated signaling pathways on liver injury. The aim of this study is to explore the function and mechanism of M <sub>3</sub>R in the regulation of liver injury. We evaluate liver injury and detect the changes in related indexes, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), hydroxyproline (HYP), and transforming growth factor-β1 (TGF-β1), after administration of an M <sub>3</sub>R agonist. Western blot analysis and qRT-PCR show that the transcription factor Sp1 and long noncoding RNA (lncRNA) Gm2199 are also changed significantly. Rescue assay is performed to further confirm that M <sub>3</sub>R contributes to the progression of hepatocyte proliferation through regulating Sp1 and Gm2199. The activated M <sub>3</sub>R can specifically regulate Gm2199 by inhibiting the expression of Sp1. Meanwhile, Gm2199 directly regulates miR-212, and ERK is a potential target of miR-212. Collectively, these findings define a novel mechanism for activating M <sub>3</sub>R to reverse liver injury, which affects hepatocyte proliferation through the Sp1/Gm 2199/miR-212/ERK axis.
Show more [+] Less [-]Bibliographic information
This bibliographic record has been provided by Directory of Open Access Journals